# RxLogix

> RxLogix builds pharmacovigilance software and provides consulting, implementation, hosting, and managed services for pharmaceutical and biotechnology companies and regulators. Its platform connects case processing, reporting, signal management, and safety oversight through shared data, with AI automation and human review controls.

- **Founded:** 2010
- **Headquarters:** Aventura, United States
- **Founders:** Raj More (Founder, Chief Architect & CEO)
- **Products:** Safety-in-a-Box, PV Case Management, PV DataHub, PV Reports, PV Signal
- **Notable:** Selected for FDA reporting and signal-management modernization in 2018; FDA publicly named the tools in 2020., EMA Safety Surveillance Suite go-live announced December 2025; EMA documents identify RxLogix as a platform processor., 2020 Frost & Sullivan Global Product Leadership Award for PV Intake & Processing.

## Products & services

- **Safety-in-a-Box** — Integrated cloud safety platform covering case management, reporting, and compliance.
- **PV Case Management** — Intake, triage, medical coding, follow-up, processing, and reporting workflows.
- **PV DataHub** — Governed pharmacovigilance data warehouse using an ICH E2B(R3) model and case versioning.
- **PV Reports** — Self-service regulatory, aggregate, and ad hoc reporting and analysis.
- **PV Signal** — Signal detection, evaluation, and lifecycle management across safety datasets.
- **PV Analytics** — Safety data analysis and visualization, integrated with PV Signal.
- **PV Publisher** — Safety-document authoring, collaborative review, version control, and publishing.
- **PV Risk Manager** — Risk-management plans, risk commitments, and coordinated oversight.
- **PV Central** — Compliance monitoring for safety operations, reporting, and business partners.
- **PV Quality** — Quality oversight within safety operations.
- **Implementation and managed services** — Migration, validation, configuration, hosting, reporting assistance, inspection support, and 24/7 help desk.
- **PVOne.AI** — Fourth-generation AI offering with agentic orchestration, domain-trained models, and human-in-the-loop controls across existing safety applications.

## Achievements

- Selected for FDA reporting and signal-management modernization in 2018; FDA publicly named the tools in 2020.
- EMA Safety Surveillance Suite go-live announced December 2025; EMA documents identify RxLogix as a platform processor.
- 2020 Frost & Sullivan Global Product Leadership Award for PV Intake & Processing.
- Inc. 5000 appearances in 2019, 2020, 2021, 2022, 2023, and 2024; ranked 3,445 in 2024.

## Latest updates

- **2026-09** — Listed a PV Reports & Analytics webinar for September 16 and industry events in Frankfurt, Amsterdam, and San José.
- **2026-07** — Reported onboarding 31 national competent authorities to EMA’s PV Signal and PV Reports platform.
- **2026-06** — Axios reported a possible sale process; no completed transaction is asserted.
- **2026-04** — Announced PVOne.AI with agentic AI orchestration across existing pharmacovigilance products.
- **2026-02** — Reported an unnamed major pharma go-live for PV Signal and PV Analytics, including migration from Oracle Empirica and a legacy risk-tracking application.
- **2025-12** — Announced EMA Safety Surveillance Suite go-live and published European and American pharma migration case studies.

## Links

- Website: https://rxlogix.com/
- LinkedIn: https://www.linkedin.com/company/rxlogix-corporation/
- Twitter/X: https://twitter.com/RxLogix
- YouTube: https://www.youtube.com/@RxLogixCorporation
- Facebook: https://www.facebook.com/rxlogix/

---

Profile page: https://yespress.io/rxlogix
Published by YesPress — https://yespress.io
Last updated: 2026-10-01